What Is PSMA?
PSMA stands for prostate-specific membrane antigen, a protein found on the surface of prostate cancer cells. Most prostate cancers produce high levels of PSMA, which makes it a useful target for imaging. A PSMA PET CT scan uses a radioactive tracer that binds to this protein, allowing the scanner to highlight prostate cancer cells wherever they are in the body.
Why PSMA PET CT Is Different from Conventional Imaging
Traditional imaging for prostate cancer, such as CT scans, MRI, and bone scans, looks for structural abnormalities. A lymph node needs to be enlarged, or a bone lesion needs to be visible, before these scans can flag a problem. By the time structural changes appear, the disease may already be more advanced.
PSMA PET CT works differently. Because it targets the cancer cells themselves through the PSMA protein, it can detect disease at a molecular level. This means it can find prostate cancer deposits that are too small to show up on conventional scans. Studies have shown that PSMA PET CT detects more sites of disease than the combination of CT and bone scan in many clinical scenarios.
When Is PSMA PET CT Used?
Doctors recommend PSMA PET CT in several common situations:
Initial staging: After a prostate cancer diagnosis, PSMA PET CT helps determine the extent of the disease. It shows whether the cancer is confined to the prostate, has spread to nearby lymph nodes, or has reached distant sites like bones or other organs. This staging information is critical for choosing between surgery, radiation, hormone therapy, or a combination.
Biochemical recurrence: After surgery or radiation therapy for prostate cancer, doctors monitor PSA (prostate-specific antigen) levels through blood tests. If the PSA starts rising again, it may indicate that cancer has returned. PSMA PET CT is particularly valuable in this situation because it can often locate the site of recurrence even when PSA levels are still relatively low, allowing for earlier and more targeted treatment.
Treatment planning: For patients being considered for targeted radiation therapy or radioligand therapy, PSMA PET CT confirms that the cancer cells express the PSMA target. This is essential before proceeding with treatments like Lu-177 PSMA therapy.
What Happens During the Scan
The process is similar to other PET CT scans. A small amount of the PSMA-targeted radioactive tracer is injected into a vein. After a waiting period of about 60 minutes, the scan is performed. You will lie on a table that passes through the scanner, and the imaging takes roughly 20 to 30 minutes. The procedure is painless and does not require any special preparation beyond what your doctor or the nuclear medicine team advises.
What the Results Show
The nuclear medicine physician analyses the images and prepares a report for your treating doctor. The report identifies areas of PSMA uptake, which indicate prostate cancer activity. It also correlates these findings with the CT images to provide an exact location.
A positive PSMA PET CT result does not automatically determine your treatment. It provides information that your doctor uses alongside other factors, including your PSA level, Gleason score, overall health, and treatment history, to decide the next steps.
PSMA PET CT and Lu-177 PSMA Therapy
One of the most significant developments in prostate cancer care is the theranostic approach. If a PSMA PET CT shows that the cancer cells strongly express PSMA, the same targeting mechanism can be used for treatment. Lu-177 PSMA therapy delivers targeted radiation directly to PSMA-expressing cancer cells. The diagnostic scan and the therapy are two sides of the same coin, which is why this approach is called theranostics.
Whether Lu-177 PSMA therapy is appropriate for a particular patient depends on multiple factors, including the stage of disease, previous treatments, and overall health. This decision is made by the treating team.
Talk to Your Doctor
If you have been diagnosed with prostate cancer or are dealing with a rising PSA after treatment, ask your doctor whether a PSMA PET CT scan could be useful in your case. The scan provides detailed information that can help guide treatment decisions at various stages of the disease.